Summary: Movement as the Best Medicine

If a pharmaceutical company developed a drug that reduced the risk of heart disease, type 2 diabetes, eight cancers, dementia, depression, falls, osteoporotic fractures, and all-cause mortality, and that improved sleep, balance, bone density, and gut microbiome diversity, and that cost nothing, the stock would be worth more than every company in the S&P 500 combined. That drug exists. It is called exercise. No one can patent it.

Across every condition in this series, the evidence points the same direction. Exercise reduces cardiovascular mortality, improves insulin sensitivity, decreases osteoarthritis pain, prevents falls (15% rate reduction per 2024 USPSTF review), slows bone loss, treats depression with effect sizes comparable to antidepressants in some analyses, and modifies the gut microbiome. The threshold for benefit is lower than most people think. Walking counts. Chair exercises count.

The brain evidence deserves special attention. A 2025 study found that higher physical activity during midlife was associated with 41% lower dementia risk, and during late life with 45% lower risk. A separate study found that higher step counts in older adults with elevated amyloid were associated with slower cognitive decline and slower tau accumulation. The benefit plateaued at moderate activity. You do not need to train for a marathon. You need to walk.

Different types of exercise benefit different cognitive domains: resistance training for global cognition, mind-body exercise for executive function, aerobic exercise for memory. The specific activity matters less than the act of doing something.

Honesty requires noting that a large 2024 meta-analysis of 341,000 participants found only a weak population-level association between baseline activity and subsequent cognition. Exercise almost certainly helps the aging brain. How much it helps any individual remains less certain than the enthusiasm sometimes suggests. But the floor of benefit is real and the ceiling of risk is essentially zero for appropriately designed programs.

The barrier is not evidence. It is infrastructure. Medicare limits physical therapy visits. SilverSneakers depends on plan participation. Community programs are inconsistently funded. The single most effective intervention in aging medicine has no reliable delivery system. If you can move, move. If you need help figuring out how, ask for a physical therapy referral and do not accept “exercise more” as a prescription.